Literature DB >> 27088971

Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells.

Itsuro Kazama, Kazutomo Saito, Asuka Baba, Tomohiro Mori, Nozomu Abe, Yasuhiro Endo, Hiroaki Toyama, Yutaka Ejima, Mitsunobu Matsubara, Masanori Yamauchi.   

Abstract

BACKGROUND: Macrolides, such as clarithromycin, have antiallergic properties. Since exocytosis in mast cells is detected electrophysiologically via changes in membrane capacitance (Cm), the absence of such changes due to the drug indicates its mast cell-stabilizing effect.
METHODS: Employing the whole-cell patch clamp technique in rat peritoneal mast cells, we examined the effects of clarithromycin on Cm during exocytosis. Using a water-soluble fluorescent dye, we also examined its effect on deformation of the plasma membrane.
RESULTS: Clarithromycin (10 and 100 μM) significantly inhibited degranulation from mast cells and almost totally suppressed the GTP-x03B3;-S-induced increase in Cm. It washed out the trapping of the dye on the surface of mast cells.
CONCLUSIONS: This study provides for the first time electrophysiological evidence that clarithromycin dose-dependently inhibits the process of exocytosis. The mast cell-stabilizing action of clarithromycin may be attributable to its counteractive effect on plasma membrane deformation induced by exocytosis.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088971     DOI: 10.1159/000445023

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  5 in total

Review 1.  Post-COVID Syndrome: The Research Progress in the Treatment of Pulmonary sequelae after COVID-19 Infection.

Authors:  Valentina Ruggiero; Rita P Aquino; Pasquale Del Gaudio; Pietro Campiglia; Paola Russo
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

Review 2.  Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases.

Authors:  Philipp M Hagemann; Stephanie Nsiah-Dosu; Jennifer Elisabeth Hundt; Karin Hartmann; Zane Orinska
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

3.  Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis.

Authors:  Itsuro Kazama
Journal:  Clin Mol Allergy       Date:  2021-12-13

Review 4.  Pathogenesis and Management of COVID-19.

Authors:  Khalid O Alfarouk; Sari T S AlHoufie; Samrein B M Ahmed; Mona Shabana; Ahmed Ahmed; Saad S Alqahtani; Ali S Alqahtani; Ali M Alqahtani; AbdelRahman M Ramadan; Mohamed E Ahmed; Heyam S Ali; Adil Bashir; Jesus Devesa; Rosa A Cardone; Muntaser E Ibrahim; Laurent Schwartz; Stephan J Reshkin
Journal:  J Xenobiot       Date:  2021-05-21

5.  α 1-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells.

Authors:  Nozomu Abe; Hiroaki Toyama; Yutaka Ejima; Kazutomo Saito; Tsutomu Tamada; Masanori Yamauchi; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2020-05-12       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.